Larimar Therapeutics Inc. (LRMR)
3.48
0.02 (0.58%)
At close: Jan 28, 2025, 2:29 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 26.75M | 26.82M | 70.10M | 68.15M | 1.01M | 49.33M | 40.78M | 32.35M | 35.59M | 58.10M | 35.52M | 9.94M |
| Short-Term Investments | 60.04M | 91.60M | n/a | 24.49M | 43.05M | 68.73M | 61.27M | 96.84M | 149.48M | 57.36M | n/a | n/a |
| Long-Term Investments | 1.34M | 1.34M | 1.34M | 1.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 630.00K |
| Other Long-Term Assets | 659.00K | 638.00K | 669.00K | 419.00K | 90.00K | 57.00K | 57.00K | 61.00K | 94.00K | 242.00K | 743.00K | n/a |
| Receivables | n/a | n/a | 208.00K | 32.00K | n/a | 1.54M | 946.00K | 347.00K | 1.32M | n/a | 1.62M | n/a |
| Inventory | n/a | n/a | -208.00K | -32.00K | 3.16M | n/a | n/a | 1.00 | n/a | n/a | n/a | n/a |
| Other Current Assets | 3.38M | 2.31M | 1.90M | 5.28M | 3.74M | 2.17M | 1.93M | 1.36M | 1.71M | 1.74M | 224.00K | 389.00K |
| Total Current Assets | 90.17M | 120.74M | 72.20M | 97.95M | 4.75M | 121.33M | 104.92M | 130.90M | 188.11M | 117.20M | 37.36M | 10.32M |
| Property-Plant & Equipment | 3.76M | 3.69M | 4.46M | 4.98M | 361.00K | 375.00K | 528.00K | 661.00K | 902.00K | 79.00K | 37.00K | 32.00K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 5.76M | 5.67M | 6.46M | 6.73M | 451.00K | 432.00K | 585.00K | 722.00K | 996.00K | 321.00K | 780.00K | 662.00K |
| Total Assets | 95.94M | 126.41M | 78.67M | 104.69M | 5.20M | 121.76M | 105.51M | 131.62M | 189.11M | 117.52M | 38.14M | 10.99M |
| Account Payables | 1.28M | 1.69M | 1.66M | 2.63M | 3.54M | 909.00K | 3.02M | 2.57M | 7.50M | 2.35M | n/a | n/a |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | -5.46M | n/a | -2.57M | -2.94M | n/a | n/a | n/a |
| Short-Term Debt | 837.00K | 1.22M | 1.19M | 1.03M | 97.00K | 5.46M | n/a | 3.59M | 2.94M | 1.38M | n/a | n/a |
| Other Current Liabilities | 7.39M | 7.80M | 6.00M | 5.33M | 2.26M | 6.94M | 4.27M | 6.30M | 9.05M | 3.17M | 2.92M | 2.93M |
| Total Current Liabilities | 9.51M | 10.71M | 8.85M | 8.99M | 5.89M | 13.31M | 7.29M | 9.89M | 16.54M | 6.90M | 2.92M | 2.93M |
| Long-Term Debt | 4.71M | 4.80M | 5.41M | 6.00M | n/a | 15.19M | 20.00M | n/a | 3.45M | 6.18M | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1 | n/a | n/a | n/a |
| Total Long-Term Liabilities | 4.71M | 4.80M | 5.41M | 6.00M | 14.92M | 15.19M | 20.00M | n/a | 3.45M | 6.18M | n/a | n/a |
| Total Liabilities | 14.21M | 15.50M | 14.25M | 14.99M | 5.89M | 28.49M | 27.29M | 9.89M | 20.00M | 13.08M | 2.92M | 2.93M |
| Total Debt | 5.55M | 5.41M | 6.00M | 6.52M | 97.00K | 20.64M | 20.00M | 3.59M | 6.39M | 7.56M | n/a | n/a |
| Common Stock | 43.00K | 43.00K | 18.00K | 15.00K | 6.00K | 37.00K | 27.00K | 27.00K | 27.00K | 23.00K | 1K | 1K |
| Retained Earnings | -188.55M | -151.60M | -116.25M | -65.61M | -23.13M | -350.94M | -289.58M | -237.55M | -179.67M | -105.39M | -68.91M | -54.88M |
| Comprehensive Income | 81.00K | -31.00K | -0.00 | 1K | 35.00K | -33.00K | -58.00K | -80.00K | -207.00K | -35.00K | n/a | n/a |
| Shareholders Equity | 81.72M | 110.90M | 64.41M | 89.69M | -694.00K | 93.27M | 78.22M | 121.73M | 169.11M | 104.44M | 35.22M | 8.06M |
| Total Investments | 61.38M | 91.60M | 1.34M | 24.49M | 43.05M | 68.73M | 61.27M | 96.84M | 149.48M | 57.36M | n/a | 630.00K |